Coherus All But Checks Out Of Biosimilars With Meitheal Adalimumab Deal

Yusimry Biosimilar Divested To Hong Kong King-Friend For $40m Upfront

 
• By Dean Rudge
  
Investing in new business while divesting in old industry with an old tree shaped as a finance pie chart graph funding a green tree
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business